Camerini davalos (29 resultados)

LEINEN, Format groß 8°, 486 Seiten, dies ist ein regulär ausgesondertes Bibliotheksexemplar aus einer wissenschaftlichen Bibliothek, keine Markierungen-Anstreichungen im Text, das Buch befindet sich in einem sehr guten Zustand --- LINEN BINDING, 486 pages, Lib.Ex., no marks/underlines, the book is in a very good condition. Shipping to abroad insured with tracking number.…

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

LEINEN, Format groß 8°, 595 Seiten, dies ist ein regulär ausgesondertes Bibliotheksexemplar aus einer wissenschaftlichen Bibliothek, keine Markierungen-Anstreichungen im Text, das Buch befindet sich in einem guten Zustand --- LINEN BINDING, 595 pages, Lib.Ex., no marks/underlines, the book is in a good condition. Shipping to abroad insured with tracking number.…

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New. pp. 438.

Paperback. Condición: Brand New. 508 pages. 9.25x6.25x1.15 inches. In Stock.

Condición: New.

Paperback. Condición: Brand New. 622 pages. 9.25x6.15x1.41 inches. In Stock.

Condición: As New. Unread book in perfect condition.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - To obey the precepts of therapeutic rationality, we should avoid treating the 'effect' when there is a way to attack the cause. But what is the cause of diabetes Diabetes is a molecular disease, that is, a disease in which important cellular components are seriously impaired. Eventually, the activities or the products arising from the impairment find expression in various ways, finally culminating in the abnormalities of diabetes. How early is early enough to attempt to delay this sequence of events What will provide us with the basis to explore ways and means of halting the progression of the pathological process What are the new approaches for the treatment of early diabetes The Fourth International Symposium on Early Diabetes, sponsored by the Diabetes Center of the New York Medical College, held in Algarve, Portugal in November 1978, from which this book evolved, attempted to answer some of these questions. A list of the participants, including their affiliations, will be found preceding the index. Rafael A. Camerini-Davalos v Acknowledgments To our sponsors, U.S.V. Pharmaceutical Corp., Pfizer Pharmaceuticals, Ames Company, Hoechst, Frankfurt; supporters, Boehringer, Manheim, Laboratoires Servier, Nordisk Laboratory, The Upjohn Company, Eli Lilly and Company, F. Hoffman La Roche; and contributors, Bayer A. G. Leverkusen, McNeil, Novo Research Institute, ICI Belgium, Hope for Diabetics Foundation, New York, we express our appreciation for the financial support which made possible the Fourth International Symposium on Early Diabetes. THE ORGANIZING COMMITTEE Rafael A. Camerini-Davalos, M.D.…

Paperback. Condición: Brand New. 548 pages. 9.61x6.69x1.25 inches. In Stock.

Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condición: As New. Unread book in perfect condition.

hardcover. Condición: Good. Ex-Library hardcover book no dust jacket, usual library marks, has some light reader wear.

Condición: new. Questo è un articolo print on demand.

PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Condición: new. Questo è un articolo print on demand.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Prediabetes in Animals.- History: The discovery of prediabetes in animals.- Hereditary diabetes in the KK mouse: An overview.- Development of microvascular and islet cell alterations in rats with spontaneous non insulin-dependent diabetes.- Development of d.…

Condición: New. Print on Demand pp. 438 66:B&W 7 x 10 in or 254 x 178 mm Perfect Bound on White w/Gloss Lam.

Condición: New. PRINT ON DEMAND pp. 438.

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Prediabetes in Animals.- History: The discovery of prediabetes in animals.- Hereditary diabetes in the KK mouse: An overview.- Development of microvascular and islet cell alterations in rats with spontaneous non insulin-dependent diabetes.- Development of diabetes in the non-obese NIDDM rat (GK rat).- Spontaneous diabetes in Macaca Nigra: Relevance to human beings with NIDDMM.- Immunological Markers.- Insulin autoantibodies in prediabetes.- Sites of the defects leading to autoimmunity in the spontaneously diabetic BB rat.- Assay for cytoplasmic islet cell antibodies using two-color immunofluorescence and rat pancreas.- Cytoplasmic islet cell autoantibodies: Prevalence and pathognomic significance.- A new marker of T lymphocite activation in type I diabetes.- Prediction of Diabetes.- Studies of prediabetes in the spontaneously diabetic BB rat.- Chemically-initiated hyperglycemia: Streptozotocin-specific T Lymphocyte reactions.- Diabetic lymphocytes tranafer and beta cell functions.- Lymphocyte subsets in prediabetes.- The in vivo visualization of insulitis: a new marker of prediabetes.- Genetic relationships between type I and type 2 diabetes mellitus.- Pathology of Prediabetes.- Kidney disease in KK mice: structural, biochemical and functional relationships.- Sequence of changes in KK mouse nephropathy.- Abnormal response to glucose in the prehyperglycemic stage.- Low insulin response: a marker of prediabetes.- Study of glucose removal rate and first phase insulin secretion in the offspring of two parents with non-insulin dependent diabetes.- Antecedent events for non-insulin dependent diabetes mellitus.- Hemostasis and endothelial disorders in prediabetes.- Mtcrochannels in prediabetes.- Population Studies.- Islet-cell and insulin autoantibodies in first-degree relatives of type I diabetics: A 5-year follow-up in a swiss population.- Childhood insulin-dependent diabetes in Japan.- Children at risk of diabetes mellitus: New York studies of families with diabetes and of children with congenital rubella syndrome.- Family studies of insulin-dependent diabetics: the U.K. experience.- Can the high risk of type I diabetes in Finland be explained by familial aggregation and by HLA haplotype distribution .- Genetic and humoral markers in IDDM patients and their families.- Development of diabetes in identical twins.- Type-specific concordance in young diabetic monozygotic twins.- The pathological lesions of the pancreas and prediabetes.- Treatment of Prediabetes.- Diabetogenicity of various protein sources in the diet of the diabetes-prone BB rat.- Effect of alpha-Glucosidase-inhibitors on blood glucose and insulin levels.- Kidney disease in KK mice: Effect of glyburide.- Kidney disease in KK mice: Effect of Glipizide.- Effect of Gliclazide on non-insulin dependent diabetes mellitus.- Plasma activity of the enzyme N-Acetyl-Beta-Glucosaminidase in healthy and diabetic subjects. Effect of treatment with a sulfonylurea drug.- Continuous insulin treatment in the Chinese hamster. A review.- Kidney disease in KK mice. Effect of Insulin.- Some characteristics of chemically-induced beta-cell lesions as possible contributing factors in diabetes.- Effects of immunosuppresion with Cyclosporine on beta cell function and clinical remission in very early overt Type I diabetes.- Immunomodulation of prediabetes in BB rats for prevention of the disease.- Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.- Prevention of Diabetes.- Regulatory T cell control of autoimmune destruction of beta cells in the BB rat.- Prevention of diabetes in the BB rat by injection of major histocompatibility complex- (MHC-) compatible bone marrow cells.- The incidence of diabetes in BB rats is decreased following acute LCMV infection.- Strategies for primary prevention of non-insulin dependent diabetes mellitus.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 436 pp. Englisch.…

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -To obey the precepts of therapeutic rationality, we should avoid treating the 'effect' when there is a way to attack the cause. But what is the cause of diabetes Diabetes is a molecular disease, that is, a disease in which important cellular components are seriously impaired. Eventually, the activities or the products arising from the impairment find expression in various ways, finally culminating in the abnormalities of diabetes. How early is early enough to attempt to delay this sequence of events What will provide us with the basis to explore ways and means of halting the progression of the pathological process What are the new approaches for the treatment of early diabetes The Fourth International Symposium on Early Diabetes, sponsored by the Diabetes Center of the New York Medical College, held in Algarve, Portugal in November 1978, from which this book evolved, attempted to answer some of these questions. A list of the participants, including their affiliations, will be found preceding the index. Rafael A. Camerini-Davalos v Acknowledgments To our sponsors, U.S.V. Pharmaceutical Corp., Pfizer Pharmaceuticals, Ames Company, Hoechst, Frankfurt; supporters, Boehringer, Manheim, Laboratoires Servier, Nordisk Laboratory, The Upjohn Company, Eli Lilly and Company, F. Hoffman La Roche; and contributors, Bayer A. G. Leverkusen, McNeil, Novo Research Institute, ICI Belgium, Hope for Diabetics Foundation, New York, we express our appreciation for the financial support which made possible the Fourth International Symposium on Early Diabetes. THE ORGANIZING COMMITTEE Rafael A. Camerini-Davalos, M.D. 552 pp. Englisch.…

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. To obey the precepts of therapeutic rationality, we should avoid treating the effect when there is a way to attack the cause. But what is the cause of diabetes? Diabetes is a molecular disease, that is, a disease in which important cellular components are.…

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -To obey the precepts of therapeutic rationality, we should avoid treating the 'effect' when there is a way to attack the cause. But what is the cause of diabetes Diabetes is a molecular disease, that is, a disease in which important cellular components are seriously impaired. Eventually, the activities or the products arising from the impairment find expression in various ways, finally culminating in the abnormalities of diabetes. How early is early enough to attempt to delay this sequence of events What will provide us with the basis to explore ways and means of halting the progression of the pathological process What are the new approaches for the treatment of early diabetes The Fourth International Symposium on Early Diabetes, sponsored by the Diabetes Center of the New York Medical College, held in Algarve, Portugal in November 1978, from which this book evolved, attempted to answer some of these questions. A list of the participants, including their affiliations, will be found preceding the index. Rafael A. Camerini-Davalos v Acknowledgments To our sponsors, U.S.V. Pharmaceutical Corp., Pfizer Pharmaceuticals, Ames Company, Hoechst, Frankfurt; supporters, Boehringer, Manheim, Laboratoires Servier, Nordisk Laboratory, The Upjohn Company, Eli Lilly and Company, F. Hoffman La Roche; and contributors, Bayer A. G. Leverkusen, McNeil, Novo Research Institute, ICI Belgium, Hope for Diabetics Foundation, New York, we express our appreciation for the financial support which made possible the Fourth International Symposium on Early Diabetes. THE ORGANIZING COMMITTEE Rafael A. Camerini-Davalos, M.D.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 552 pp. Englisch.…